Citadel Advisors’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $282K | Sell |
55,065
-51,437
| -48% | -$263K | ﹤0.01% | 4683 |
|
|
2025
Q1 | $146K | Sell |
106,502
-1,520,257
| -93% | -$2.08M | ﹤0.01% | 5011 |
|
|
2024
Q4 | $5.03M | Sell |
1,626,759
-1,067,366
| -40% | -$3.3M | ﹤0.01% | 1802 |
|
|
2024
Q3 | $20.7M | Buy |
2,694,125
+1,462,368
| +119% | +$11.3M | ﹤0.01% | 843 |
|
|
2024
Q2 | $10.6M | Buy |
1,231,757
+765,639
| +164% | +$6.57M | ﹤0.01% | 1187 |
|
|
2024
Q1 | $3.7M | Buy |
466,118
+264,303
| +131% | +$2.1M | ﹤0.01% | 1989 |
|
|
2023
Q4 | $2M | Buy |
+201,815
| New | +$2M | ﹤0.01% | 2397 |
|
|
2023
Q3 | – | Sell |
-164,986
| Closed | -$548K | – | 6499 |
|
|
2023
Q2 | $548K | Sell |
164,986
-8,076
| -5% | -$26.8K | ﹤0.01% | 3564 |
|
|
2023
Q1 | $684K | Sell |
173,062
-192,323
| -53% | -$760K | ﹤0.01% | 3561 |
|
|
2022
Q4 | $2.65M | Sell |
365,385
-112,879
| -24% | -$818K | ﹤0.01% | 2329 |
|
|
2022
Q3 | $1.73M | Buy |
478,264
+64,069
| +15% | +$232K | ﹤0.01% | 2873 |
|
|
2022
Q2 | $1.88M | Buy |
414,195
+16,010
| +4% | +$72.5K | ﹤0.01% | 2794 |
|
|
2022
Q1 | $3.02M | Sell |
398,185
-63,049
| -14% | -$478K | ﹤0.01% | 2548 |
|
|
2021
Q4 | $5.05M | Buy |
461,234
+52,709
| +13% | +$577K | ﹤0.01% | 2091 |
|
|
2021
Q3 | $5.28M | Buy |
408,525
+83,137
| +26% | +$1.07M | ﹤0.01% | 1998 |
|
|
2021
Q2 | $3.69M | Buy |
325,388
+2,967
| +0.9% | +$33.7K | ﹤0.01% | 2518 |
|
|
2021
Q1 | $3.59M | Sell |
322,421
-36
| -0% | -$400 | ﹤0.01% | 2504 |
|
|
2020
Q4 | $3.69M | Sell |
322,457
-17,861
| -5% | -$204K | ﹤0.01% | 2021 |
|
|
2020
Q3 | $3.69M | Buy |
+340,318
| New | +$3.69M | ﹤0.01% | 1734 |
|